47 reports

  • Risk Factors and Comorbidities for CKD
  • 4.1 BIBLIOGRAPHY

KIDNEY INTERNATIONAL SUPPLEMENTS; ##(##): ##-##.

  • Chronic Disease
  • Renal Disease
  • United Kingdom
  • United States
  • Forecast
  • Stages of chronic kidney disease
  • Aranesp late-phase trial data in anemia in chronic kidney disease

American Journal of Kidney Diseases, ##(##), ##-## < DOI> ##. ##/ ##-##(##)##-##< / DOI>.

  • Renal Disease
  • Japan
  • United States
  • Amgen Inc.
  • Roche Group
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Dormant Projects

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview End-stage kidney disease is the complete or almost complete failure of the kidneys to work.

  • Chronic Disease
  • Renal Disease
  • United States
  • World
  • Novartis AG
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline by VESSL Therapeutics Ltd, H1 2018

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview End-stage kidney disease is the complete or almost complete failure of the kidneys to work.

  • Renal Disease
  • Therapy
  • United States
  • World
  • CTI BioPharma Corp.
  • 1. COMPREHENSIVE DATA RELATED TO END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) CLINICAL TRIALS BY REGION,
  • TOP COMPANIES PARTICIPATING IN END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS

END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2019* CLINICAL TRIALS BY PHASE IN E## COUNTRIES END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUT

  • Chronic Disease
  • Clinical Trial
  • Hormone
  • Renal Disease
  • World
  • Polycystic Kidney Disease - Overview
  • Polycystic Kidney Disease - Discontinued Products

This treatment has been recommended to slow the progression of cyst development and renal insufficiency of autosomal dominant polycystic kidney disease (ADPKD) in adults with chronic kidney disease (CKD) stage ## to ## at initiation of treatment with eviden

  • Renal Disease
  • Therapy
  • United States
  • Company
  • Product Initiative
  • POLYCYSTIC KIDNEY DISEASE THERAPEUTICS, GLOBAL, CLINICAL TRIALS BY REGION (%), 2018*
  • TOP COMPANIES PARTICIPATING IN POLYCYSTIC KIDNEY DISEASE THERAPEUTICS CLINICAL TRIALS

POLYCYSTIC KIDNEY DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* POLYCYSTIC KIDNEY DISEASE THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* POLYCYSTIC KIDNEY DISEASE THERAPEUTICS CLINICAL TRIALS, GL

  • Pharmaceutical
  • Renal Disease
  • World
  • Product Initiative
  • Otsuka Pharmaceutical Co., Ltd.
  • Clinical Trial profile. 327 Trial Title
  • Clinical Trial profile. 285 Trial Title

CLINICAL TRIALS BY END POINT STATUS ANEMIA IN CHRONIC KIDNEY DISEASE (RENAL ANEMIA) THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018* ANEMIA IN CHRONIC KIDNEY DISEASE (RENAL ANEMIA) THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT STATUS, 2018* AN

  • Pharmaceutical
  • Renal Disease
  • World
  • Product Initiative
  • F. Hoffmann-La Roche Ltd.
  • CHRONIC KIDNEY DISEASE (CKD)
  • UPDATES

GENE THERAPY GENE THERAPY COULD BE ONE OF THE PERFECT TREATMENT FOR RENAL DISEASES BECAUSE OF LIMITED THERAPEUTIC MOLECULE AND MINIMIZED SYSTEMIC EFFECT IN THE KIDNEY.

  • Renal Disease
  • Angion Biomedica Corp.
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • Eli Lilly & Co.

Kidney Disease Global Clinical Trials Review, H##, 2017 Table of Contents ## List of Tables ## List of Figures ## Report Guidance ## GlobalData Clinical Trials Report Coverage ## Clinical Trials by Region ## Clinical Trials and Average Enrollment by Country ## Top Five Countries Contributi

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Renal Disease
  • World
  • END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS, CENTRAL AND SOUTH AMERICA, TOP
  • END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS CLINICAL TRIALS, MIDDLE EAST AND AFRICA, TOP FIVE

END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2017* CLINICAL TRIALS BY PHASE IN E## COUNTRIES END-STAGE KIDNEY DISEASE (END-STAGE RENAL DISEASE OR ESRD) THERAPEUT

  • Chronic Disease
  • Clinical Trial
  • Renal Disease
  • Therapy
  • World
  • Stage of Development
  • Stage of Development

PRODUCTS IN PHASE II/ III AND I/ II ARE REFLECTED UNDER PHASE III AND PHASE II, RESPECTIVELY Phase III ## ## Phase II ## ## Phase I ## ## IND/ CTA Filed ## ## Preclinical ## ## Discovery ## ## Total ## ## Stage of Development Company Universities/ Institutes Source: GBI Research Angio

  • Molecular Diagnostics
  • Pathology
  • Pharmaceutical
  • Renal Disease
  • Therapy
  • Polycystic Kidney Disease - Overview
  • Polycystic Kidney Disease - Therapeutics Assessment

It also conducts preclinical development programs in chronic kidney disease including diabetic nephropathy and polycystic kidney disease.

  • Renal Disease
  • Therapy
  • United States
  • Company Operations
  • Product Initiative
  • DRUG FOR KIDNEY DISEASES - DRUG PROFILE
  • CHRONIC KIDNEY DISEASE (CHRONIC RENAL FAILURE)

Chronic kidney disease is the slow loss of kidney function over time.

  • Diabetes
  • Renal Disease
  • United States
  • Company
  • Product Initiative

The report focuses on drugs and therapies being evaluated for End-Stage Kidney Disease (end-stage renal disease or ESRD) treatment in active clinical development phases including phase ##, phase ##, phase ## and phase ## clinical trials.

  • Chronic Disease
  • Clinical Trial
  • Pathology
  • Renal Disease

Polycystic Kidney Disease Ongoing Global Clinical Trials Analysis and Outlook ## Table of Contents ##. ## List of Figures ##. ## List of Tables ## Key Findings, 2018 ##. ## Snapshot ##. ## Overview of Polycystic Kidney Disease Trials ## Clinical Trials Trends to 2022 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology
  • Renal Disease
  • DRUG FOR KIDNEY DISEASES - DRUG PROFILE
  • SMALL MOLECULES FOR CHRONIC KIDNEY DISEASE - DRUG PROFILE

Chronic kidney disease is the slow loss of kidney function over time.

  • Cell Therapy
  • Renal Disease
  • United States
  • Company
  • Product Initiative

Insights into Polycystic Kidney Disease Pipeline ##.

  • Chronic Disease
  • Renal Disease
  • World

Insights into End Stage Renal Disease (ESRD) Pipeline ##.

  • Chronic Disease
  • Renal Disease
  • World

End-Stage Kidney Disease - Pipeline Insight, 2019 ##.

  • Renal Disease
  • Therapy

Polycystic Kidney Disease - Pipeline Insight, 2019 ##.

  • Renal Disease
  • Therapy

2019 Polycystic Kidney Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology
  • Renal Disease

2019 End Stage Renal Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology
  • Renal Disease

2019 End Stage Kidney Disease Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025 ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Pathology
  • Renal Disease

2019 Polycystic Kidney Disease Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Renal Disease
  • APAC

2019 End-Stage Renal Disease(ESRD) Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Renal Disease
  • APAC

2019 End-Stage Kidney Disease Ongoing Clinical Trials Study- Companies, Countries, Drugs, Phases, Enrollment, Current Status and Markets ##.

  • Chronic Disease
  • Clinical Trial
  • Drug Development
  • Renal Disease
  • APAC
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Overview
  • End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics Development

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Therapeutics Development PIPELINE OVERVIEW Number of Products under Development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD), H## 2017 Number of Produ

  • Pharmaceutical
  • Renal Disease
  • United States
  • World
  • CTI BioPharma Corp.
  • Renal Diseases, Global, Overall
  • Renal Diseases, Global, Percentage

Targeting the MCP-##/ CCR## System in Diabetic Kidney Disease.

  • Chronic Disease
  • Pathology
  • Renal Disease
  • Deals & Alliance
  • Galectin Therapeutics Inc.
  • Top Companies Participating in Polycystic Kidney Disease Therapeutics Clinical Trials
  • Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2016*

Proportion of Polycystic Kidney Disease to Genetic Disorders Clinical Trials, E## Countries (%), 2016* Proportion of Polycystic Kidney Disease to Genetic Disorders Clinical Trials, E## Countries (%), 2016* Proportion of Polycystic Kidney

  • Drug Development
  • Genetic Disorder
  • Renal Disease
  • World
  • Product Initiative